13F-HR filed by HealthCor Management, L.P.
HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-15, with 22 holding rows worth $109,111,527.
- Accession
- 0001343781-23-000001
- Filer
- CIK 1343781
- Filed
- 2023-02-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 22 entries on the cover page, a total value of $109,111,527 stated on the cover page (in dollars after the unit check, H1), rows summing to $109,111,523 with VALUE read as dollars as filed, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 367,765 | $38,059,999 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 321,380 | $36,393,071 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 164,440 | $7,534,640 | dollars as filed | |
| ACRIVON THERAPEUTICS INC | 004890109 | CMN | 284,201 | $3,273,995 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 3,880,900 | $3,259,956 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 110,000 | $2,874,300 | dollars as filed | |
| CONMED CORP COM | 207410101 | Stock | 27,500 | $2,437,600 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 20,000 | $2,388,800 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 70,000 | $1,781,500 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 60,000 | $1,572,000 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 5,750 | $1,525,762 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 30,000 | $1,314,300 | dollars as filed | |
| GERON CORP | 374163103 | COM | 500,000 | $1,210,000 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 5,000 | $1,112,300 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 50,000 | $978,500 | dollars as filed | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 120,000 | $960,000 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 3,500 | $881,580 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 15,000 | $792,750 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 150,000 | $744,000 | dollars as filed | |
| EQRX INC | 26886C115 | *W EXP 12/17/202 | 35,239 | $9,451 | dollars as filed | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W122 | *W EXP 10/23/202 | 78,059 | $4,340 | dollars as filed | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 29,776 | $2,679 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001343781-23-000001 | this filing | 2023-02-15 | acceptance time not in the bulk data set |